News

Femtech Company Elvie Raises a £58M Series C to Invest in Product Development and Growth

Leading UK-based femtech company Elvie has just announced the closing of a £58M Series C. The round was led by BFG with participation from funds and accounts managed by BlackRock, a consortium including Hiro Capital and Westerly Winds, Octopus Ventures and PPGL. Elvie was founded in 2013 by Tania Boler. Its current product line-up includes Elvie Trainer, an app-connected Kegel trainer, Elvie…

Organon and ObsEva Enter Global License Agreement for Preterm Labor Treatment

Every year, an estimated 15 million babies are born preterm. Organon, a global women’s health company spun out of Merck and ObsEva, a biopharmaceutical company dedicated to improving women’s reproductive health have now announced that the companies have entered into an agreement whereby Organon will license the global development, manufacturing and commercial rights to ebopiprant (OBE022). Ebopiprant is an investigational, orally active,…

Nurx Launches Urgent Care Starting with Overnight Delivery of Emergency Contraception

Nurx, the largest digital practice for women’s health, announced today it is expanding its services to offer urgent access to the morning-after pill, with prioritized medical consultations 7 days per week and overnight shipping. This marks the launch of Nurx Now, the company’s new urgent care service, which will expand soon to offer additional solutions for immediate health needs. Nurx already provides…

Female DTC Gut Health Brand her1 Closes a €5.5M Series A to Invest in Growth and Product Development

Women’s wellness brand her1 has announced the closing of €5.5M Series A let by Five Seasons Ventures. The DTC company sells plant-based products that support female gut health. The investment will be used to further grow in the European market and for new product development. Other participants in the round were previous seed investors Rheingau Founders and IBB Ventures. her1 was founded…

Indian Inito Launches its Fertility Hormone Tracker in the U.S.

Inito, a new home fertility test, announced its launch to the U.S. market. The Inito device, paired with a smartphone app, measures the actual hormone values for estrogen, luteinizing hormone and progesterone, and gives users data to guide decisions through the conception process. In addition to the U.S. launch, Inito is also launching a new ‘Hormone Charts’ feature in the app allowing…

Women’s Wellness CBD Brand House of Wise Raises a $2M Seed Round to Invest in Growth

Female-founded CBD brand House of Wise has raised $2M in seed funding to improve the lives of women everywhere through community, content, and trustworthy CBD products. The round was led by Sugar Capital, with participation from Selva Ventures, Max Ventures, Dream Ventures, and notable strategic angels NBA Star Baron Davis, Fabletics Co-founder Jack McCue, Former President & COO of Focus Brands, Kat Cole, and leading millennial women’s podcast…

Sexual Wellness Brand maude Raises a $5.8M Series A to Invest in Growth and Internationalization

maude, a modern and inclusive sexual wellness company taking on the legacy industry, has announced the close of an oversubscribed $5.8M Series A. To date, the brand has successfully raised $10M over four rounds of funding making it one of the most VC-backed sexual wellness personal care companies. The raise was led by True Beauty Ventures, a beauty and wellness-focused fund that grows early-stage brands in the…

INVO Bioscience Appoints Barbara Levy as Senior VP, Global Clinical Integration to Drive the Company’s Global OB/GYN Channel Strategy

INVO Bioscience, a medical device company focused on commercializing the world’s only in vivo Culture System (IVC), INVOcell, an effective and affordable treatment for patients diagnosed with infertility, today announced the appointment of Barbara Levy, M.D., FACOG, FACS as the Company’s Senior VP, Global Clinical Integration. Dr. Levy recently serving as Vice President, Health Policy at the American College of Obstetricians and Gynecologists…